What is the current Price Target for the Chugai Pharmaceutical stock?

The average Chugai Pharmaceutical target price is ¥9,486.00. This is 43.38% higher than the current stock price. The highest price target is 111.08%, the lowest is 8.39%. 17 Analysts have issued a price target Chugai Pharmaceutical 2027 .

How high will the Chugai Pharmaceutical stock rise?

No reliable answer can be given as to how high the Chugai Pharmaceutical stock will rise. The performance of stocks, including the Chugai Pharmaceutical stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Chugai Pharmaceutical stock today?

The performance of Chugai Pharmaceutical stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Chugai Pharmaceutical stock fall?

The decline in Chugai Pharmaceutical stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Chugai Pharmaceutical Forecast, price target & analysts

¥6,602.00

0.72%

Tokyo, Sep 25, 03:15 pm JST. Closed.

ISIN

JP3519400000

Symbol

4519

Index

Nikkei 225

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Chugai Pharmaceutical Target price 2026 - Analyst rating & recommendation

Chugai Pharmaceutical Classifications & Recommendation

Buy

70%

Hold

30%

Chugai Pharmaceutical Price Target

Target Price	¥9,486.00
Price	¥6,616.00
Potential	43.38% register free of charge
Number of Estimates	17

	17 Analysts have issued a price target Chugai Pharmaceutical 2027 . The average Chugai Pharmaceutical target price is ¥9,486.00. This is 43.38% register free of charge higher than the current stock price. The highest price target is ¥13,965.00 111.08% register free of charge , the lowest is ¥7,171.00 8.39% register free of charge .
	A rating was issued by 20 analysts: 14 Analysts recommend Chugai Pharmaceutical to buy, 6 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2027 of 43.38% register free of charge . Most analysts recommend the Chugai Pharmaceutical stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Revenue Billion ¥	1,257.94	1,395.41
	7.46%	10.93%
EBITDA Margin	48.63%	52.73%
	3.77%	8.43%

18 Analysts have issued a sales forecast Chugai Pharmaceutical 2026 . The average Chugai Pharmaceutical sales estimate is

unlock

. This is

unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics:

2025	¥1.3t	7.46%
2026	¥1.4t 10.93% unlock
2027	¥1.5t 10.11% unlock
2028	¥1.7t 9.04% unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share ¥	263.73	310.61
	12.05%	17.78%
P/E		21.41
EV/Sales		7.27

18 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	¥263.73	12.05%
2026	¥310.61 17.78% unlock
2027	¥357.91 15.23% unlock
2028	¥404.39 12.99% unlock

Current	23.22	18.27%
2026	21.41 7.78% unlock
2027	18.58 13.22% unlock
2028	16.44 11.52% unlock

Based on analysts' sales estimates for 2026, the Chugai Pharmaceutical stock is valued at an EV/Sales of

unlock

and an P/S ratio of

unlock

This results in the following potential growth metrics and future valuations:

Current	7.56
2026	7.27 3.80% unlock
2027	6.60 9.18% unlock
2028	6.06 8.29% unlock

Current	8.27	11.13%
2026	7.96 3.77% unlock
2027	7.23 9.18% unlock
2028	6.63 8.29% unlock

Chugai Pharmaceutical...

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 70.15%

Tencent Holdings Ltd. 56.53%

Uber Technologies 48.83%

Siemens Energy 47.15%

BYD 47.08%

Adidas 46.64%

Deutsche Telekom 38.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now